News & Analysis as of

Letters of Intent Pharmaceutical Industry

Cadwalader, Wickersham & Taft LLP

The Delaware Court of Chancery Rejects Termination of Merger Agreement Based on Material Adverse Effect

In Channel Medsystems, Inc. v. Boston Scientific Corporation, the Delaware Court of Chancery rejected an attempt by Boston Scientific to terminate and thus avoid consummating a merger agreement with Channel on the grounds...more

Goodwin

Deal Watch: XBrane Biopharma Signs Letter of Intent With CR Pharma Regarding Xlucane

Goodwin on

On January 15, 2018, Swedish company XBrane Biopharma issued a press release stating that, in December 2017, it signed a non-binding letter of intent with Chinese company CR Pharma regarding XLucane, a ranibizumab biosimilar....more

Carlton Fields

Expect Focus – International, Summer 2015

Carlton Fields on

In This Issue: - TTIP’s Impact on U.S. and EU Trade Relations - Proposed Innovation Box Legislation - Justice Department Recovers Nearly $6 Billion From False Claims Act Cases in 2014 - Rules...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide